Teva has “built commercial inventory infringing our patents,” Rick Shea, chief financial officer of Cambridge, Massachusetts-based Momenta, said in an interview. “Teva is free to enter the market if they are not infringing our patents.” http://www.bloomberg.com/news/2010-12-02/momenta-pharmaceuticals-sues-teva-for-patent-infringement.html